Stanford Medicine will open a new Center for Definitive and Curative Medicine (CDCM) to treat people with genetic diseases using stem cells and gene therapies. The center is a joint-initiative with the school of medicine, Stanford Health Care and Stanford Children’s Health.
Researchers at the Stanford University School of Medicine have discovered the combinations of biological and chemical signals needed to rapidly generate human cell types from human embryonic stem cells, according to Stanford Medicine News. Pure populations of up to 12 cell types can now be created in five to nine days, as opposed to the weeks or months previously required.
Two researchers from the Stanford School of Medicine have made breakthrough discoveries about heart cells that could aid scientists hoping to test drugs on lab-grown human heart cells. They have found that heart cells grown from stem cells require tension to develop properly and that cells grown in a long, thin shape will contract more strongly.
An interdisciplinary team of Stanford researchers has discovered a new mechanism for tracking stem cells after transplantation, in a breakthrough that may have broad implications for the future of effective stem cell therapy.
Researchers at the School of Medicine recently developed a new procedure designed to remove kidney-transplant patients’ dependency on immune-suppressing drugs. Transplant recipients must typically continue to take two to three immune system suppressing drugs for the remainder of their lives, following the transplant procedure. While the drugs prevent transplant recipients’ bodies from rejecting the kidney, these drugs include numerous side effects and do not always prevent kidney failure. The new technique differs from standard kidney-transplant procedures by implanting stem cells from the kidney donor’s blood into the transplant recipient’s lymph nodes, spleen and thymus.
With the addition of four proteins, adult human skin cells can be transformed into neurons over a month-long period. The findings, reported yesterday in Nature, suggest a process that doesn’t require the reprogrammed adult somatic cells called induced pluripotent stem (iPS) cells.
A new procedure developed by the School of Medicine enables couples to make the decision to donate embryos without interacting with the researchers themselves.
Short-term treatment with immune system-suppressing drugs allows human embryonic stem cells to survive and even prosper in mice, according to School of Medicine researchers. The group, led by associate professor Joseph Wu, published its findings in Cell Stem Cell yesterday.